company dropping glp-1 coverage 2025 GLP-1s and Obesity Coverage: Differing Perspectives for Employers and Health Plans GLP-1 Trends: Costs & Coverage

11 Although low concentrations of PPA may be beneficial, humans with impairments in PPA metabolism (that is, propionic or methymalonic acidemia, holocarboxylase, biotinidase or B12 deficiency, valproate or ethanol exposure) exhibit neurodevelopmental conditions with behavioral and biochemical similarities to ASD

These products have not been independently tested for efficacy or safety, but each ingredient has been scientifically studied and shown to safely deliver positive results and improve the conditions noted

Facial change alone cannot distinguish GLP-1 use from diet and exercise

Other GLP-1 receptor agonists such as semaglutide (Ozempic) and dulaglutide (Trulicity) are licensed only for diabetes management

Arixtra (fondaparinux): 7-day deferral

Many state health departments also maintain lists of approved disposal sites